Fentanyl Vaccine Potential ‘Game Changer’ for Opioid Epidemic 

Study Suggests New Vaccine Could Prevent Deadly Opioid from Entering the Brain

By Laurie Fickman 713-743-8454

November 14, 2022

A research team led by the University of Houston has developed a vaccine targeting the dangerous synthetic opioid fentanyl that could block its ability to enter the brain, thus eliminating the drug’s “high.” The breakthrough discovery could have major implications for the nation’s opioid epidemic by becoming a relapse prevention agent for people trying to quit using opioids. While research reveals Opioid Use Disorder (OUD) is treatable, an estimated 80% of those dependent on the drug suffer a relapse. 

The findings, published in the journal Pharmaceutics, could not be timelier or more in demand: Over 150 people die every day from overdoses of synthetic opioids including fentanyl, which is 50 times stronger than heroin and 100 times stronger than morphine. Consumption of about 2 milligrams of fentanyl (the size of two grains of rice) is likely to be fatal depending on a person’s size.  

Similar Posts

  • Texas scientists create fentanyl vaccine to combat opioid epidemic

    By Adithi Ramakrishnan | The Dallas Morning News To combat the fentanyl epidemic in the United States, researchers at the University of Houston have created a fentanyl vaccine that could help prevent overdoses. They aim to test the vaccine in a human trial within the next year. Fentanyl is a synthetic opioid drug that kills…

  • New study highlights opioid overdose risk following release from Oregon prisons

    By Sheraz Sadiq (OPB) In Oregon, people released from prison were 10 times more likely to overdose on opioids compared to the general population, according to a new study that tracked prison release and overdose data from 2014 to 2018. The risk of overdose doubled during the first two weeks of release, and formerly incarcerated women were…

  • SAMHSA Applauds Expansion of Access to Medication for Opioid Use Disorder (MOUD)

    The Substance Abuse and Mental Health Services Administration (SAMHSA) applauds provisions included in the 2023 Consolidated Appropriations Act (P.L. 117-328) that will significantly expand access to medication for opioid use disorder (MOUD). The act, signed into law by President Biden on Dec. 29, 2022, amended the Controlled Substances Act to eliminate the requirement for qualified…

Leave a Reply

Your email address will not be published. Required fields are marked *